ARS Pharmaceuticals Raises $55M in Series D Funding - FinSMEs
By FinSMEs. -. August 31, 2021. ARS Pharmaceuticals, a San Diego CA-based pharmaceutical company, raised $55M in Series D funding. The round was led by SR One with participation …
OFF
ARS Pharmaceuticals Raises $55M In Series D Funding - FinSMEs
6 days from now
By FinSMEs. -. August 31, 2021. ARS Pharmaceuticals, a San Diego CA-based pharmaceutical company, raised $55M in Series D funding. The round was led by SR One with participation …
finsmes.com
OFF
ARS Pharmaceuticals Raises $55 Million In Series D Funding For …
6 days from now
San Diego, Calif. – August 31, 2021 – ARS Pharmaceuticals, Inc., a pharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from …
ars-pharma.com
OFF
ARS Pharmaceuticals Raises $55 Million In Series D Funding For …
6 days from now
Aug 31, 2021 · ARS Pharmaceuticals Raises $55 Million in Series D Funding for Launch Preparations of Neffy™ (epinephrine nasal spray) ... has closed on a Series D financing of $55 …
prnewswire.com
OFF
ARS Pharmaceuticals Raises $55 Million In Series D Funding For …
6 days from now
Aug 31, 2021 · ARS Pharmaceuticals Raises $55 Million in Series D Funding for Launch Preparations of Neffy™ (epinephrine nasal spray) PRESS RELEASE PR Newswire Aug. 31, …
businessinsider.com
OFF
ARS Pharma Raises $55M - San Diego Business Journal
6 days from now
Sep 12, 2021 · ARS Pharmaceuticals, a pre-commercial pharmaceutical company, raised $55 million in Series D funding to back preparations for the launch of its lead product Neffy, an …
sdbj.com
OFF
ARS Pharmaceuticals Raises $55 Million In Series D Funding - San …
6 days from now
ARS Pharmaceuticals, a pre-commercial pharmaceutical company, raised $55 million in Series D funding to back preparations for the launch of its lead product Neffy, an epinephrine nasal …
pressreader.com
OFF
ARS Pharmaceuticals - Raised $75M Funding From 5 Investors
6 days from now
Oct 30, 2024 · List of ARS Pharmaceuticals's institutional investors. SR One, located in Redwood City (United States), made their first investment in ARS Pharmaceuticals on Aug 31, 2021 in …
tracxn.com
OFF
ARS Scores Deal Worth Up To $465M - San Diego Business Journal …
6 days from now
21 hours ago · Launched in 2015, Carmel Valley-based ARS has received $315 million in funding. In 2021, it raised $55 million in Series D funding in preparation for the launch of its lead …
sdbj.com
OFF
ARS Pharmaceuticals Snags $55M In Series D Funding
6 days from now
Tuesday, August 31, 2021 ARS Pharmaceuticals Snags $55M In Series D Funding. San Diego-based "ARS Pharmaceuticals, which is developing an epinephrine nasal spray designed to …
socaltech.com
OFF
Wilson Sonsini Advises SR One On ARS Pharmaceuticals’ $55 …
6 days from now
Sep 8, 2021 · On August 31, 2021, ARS Pharmaceuticals, Inc., a pharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from …
wsgr.com
OFF
Series D - ARS Pharmaceuticals - 2021-08-31 - Crunchbase
6 days from now
Aug 31, 2021 · FinSMEs — ARS Pharmaceuticals Raises $55M in Series D Funding . News • Aug 31, 2021. ars-pharma.com — ARS Pharmaceuticals Raises $55 Million in Series D Funding …
crunchbase.com
OFF
Firm Advises ARS Pharmaceuticals On IP Matters Related To $55 …
6 days from now
Wilson Sonsini Goodrich & Rosati advises ARS Pharmaceuticals on all IP matters and represented the company in IP matters related to the transaction. “This additional funding will …
wsgr.com
OFF
ARS Pharmaceuticals Raises $55 Million In Series D Funding
6 days from now
Aug 31, 2021 · ARS Pharmaceuticals, Inc. has closed on a Series D financing of $55 million led by SR One with participation from RA Capital Management, and one other U.S.-based, …
biospace.com
OFF
Ars Pharmaceuticals, Inc. Raises $55m In Venture Funding
6 days from now
ARS Pharma Raises $55M. ARS Pharmaceuticals, a pre-commercial pharmaceutical company, raised $55 million in Series D funding to back preparations for the launch of its lead product …
selligence.com
OFF
ARS Pharmaceuticals, Inc. – Funding, Valuation, Investors, News
6 days from now
Our mission at ARS Pharmaceuticals is to provide at-risk patients and their families better protection from severe allergic reactions. ... Funding Rounds 1. ... 14.10.2021: Series D: $55M …
parsers.vc
OFF
ARS Pharmaceuticals Raises $55 Million In Series D Funding
6 days from now
SAN DIEGO, Aug. 31, 2021 /PRNewswire/ -- ARS Pharmaceuticals Inc., a pharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves …
biospace.com
OFF
ARS Pharmaceuticals Raises $55 Million In Series D Funding For …
6 days from now
Sep 2, 2021 · ARS Pharmaceuticals Raises $55 Million in Series D Funding for Launch Preparations of Neffy™ (epinephrine nasal spray) Home » ARS Pharmaceuticals Raises $55 …
redpeppermergers.com
OFF
ARS Pharmaceuticals’ $55 Million Series D Financing
6 days from now
Sep 14, 2021 · ARS Pharmaceuticals’ $55 Million Series D Financing; ARS Pharmaceuticals’ $55 Million Series D Financing. September 14, 2021 Martina Bellini. Tagged: Bridget Balisy Dan …
globallegalchronicle.com
OFF
Augury Raises $55M In Series D Funding - FinSMEs
6 days from now
By FinSMEs. -. October 14, 2020. Augury, a NYC-based AI-based Machine Health solution provider, secured $55m in Series D funding. The round was led by Qumra Capital, with …
finsmes.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension